727-5 Differential Role of Circulating and Ventricular ANP as a Marker for Cardiac Filling Pressures and Ventricular Remodeling in a Model of Pacing Induced Heart Failure and Cardiac Hypertrophy  by Redfield, Margaret M. et al.
lACC February 1995 ABSTRACTS 133A
ing day 4 of infection. LD50 = 300 mg!kg). placebo or uninfected controls.
The pathology and microvasculature were blindly scored. and whole heart
norepinephrine (NE) content determined by HPLC. The mean cardiac NE and
pathological scores on day 28 (cardiomyopathy stage) are:
Chlor Placebo Unlnfected
Ilg/kg/min. ic). and subjected to four 8 minute periods of regional ischemia
(LAD occlusion) and reperfusion, Myocardial segment shortening (55) was
monitored throughout the stunning protocol and for 2 hours following the fi-
nal occlusion. Results: (55. % of baseline. ' p < 0,05 vs. saline. t p < 0,05 vs,
corresponding dose of GP531 alone):
NE (nM/L)
Path Score
5362 ± 389*
1.3 ± 0.6*
3382 ± 170
30 ± 0.1
5719 ± 60
00 ± 0.0
Treatment Baseline Occlusion 4 Reperfusion
1 hr 2 hr
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There was also significant amelioration of microvascular spasm in the Chlor
treated hearts. The mortality decreased from 42% (20/48) to 32% (14/44. p <
0.05).
We conclude that ganglionic blockade prevents the reduction in cardiac
norepinephrine levels in this murine model of myocarditis-cardiomyopathy.
Blocking sympathetic activation can significantly reduce the mortality. patho-
logical damage and microvascular angiopathy in the multifactorial process
leading from initial cardiac damage to the development of cardiomyopathy.
19 ± 2
38 ± 4'
57 ± 3'
30 ± 4,t
57 ± 1
36 ± 1*
45± 1*+
41 ± 1*+
MYOVEL Illm/sl
15 ± 2
39 ± 8'
47 ± 3'
31 ± 6,t
4.0 ± 0,1
2.3±0,1*
3.0 ± 0,1*+
2.6±0.1*
MYO%
-15±4
-10± 5
-11 ±6
-19± 5
226 ±7
257 ± 9*
236 ± 13
183± 14*+
APDSO Imsl
100
100
100
100
158± 9
121 ± 5*
154 ± 10+
165 ± 13+
Vmax (Vis)
-78 ± 0.8
-71 ± 0,8*
-74 ± 1*+
-76 ± 1+
RMP(mV)
Saline In ~ 6)
GP531 (1. n ~ 5)
GP531 (10. n ~ 6)
8SPT + GP531 (10. n ~ 4)
CONTROL
DCM
OCM/ACEI
OCM/AT-BLOCK
, p < 0.05 vs. saline. t p < 0.05 vs, corresponding dose of GP531 alone
*p < 0.05 vs CONTROL. +p < 0,05 vs DCM
MYO membrane potential at the end of MYO contraction increased with
DCM and DCM/ACEI (4.9 ± 1.9*.4.4 ± 2.4*mV) compared to CONTROL (0.8
± 0.3 mY) but was normalized with DCM/AT-BLOCK (1.4 ± 0.9 mY). Thus.
ACEI during the progression of DCM improved MYO function whereas AT-
BLOCK had selective effects on MYO electrophysiology.
Summary: These findings suggest that ACEI and AT-BLOCK have unique
and different mechanisms of action with cardiomyopathic disease.
Differential Effects of Chronic Angiotensin
Converting Enzyme (ACE) Inhibition and Angiotensin
II (AT-II) Receptor (AT1 AT-II) Blockade on Myocyte
Excitation and Contraction In Dilated
Cardiomyopathy
Rupak Mukherjee, Henry H, Holzgrefe, James R, Powell. William H. Koster, Francis
G. Spinale. Med Univ ofSouth Carolina, Chas. SC; Bristol Myers Squibb Research
Institute. Princeton. NJ
AT-II production and AT1 AT-II receptor activation have been suggested to
contribute to the progression of dilated cardiomyopathy (DCM). However.
the direct effects of chronic ACE inhibition (ACEI) or specific ATl AT-II re-
ceptor blockade (AT-BLOCK) on myocyte (MYO) electrophysiology and con-
tractility with the progression of DCM are unknown. Accordingly. simulta-
neous indices of isolated MYO membrane potential (resting; RMP. max up-
stroke velocity; Vmax, time to 90% repolarization; APD90) and contraction
(percent; MYO% and velocity of shortening; MYOVEL) were obtained from
4 groups of dogs (n = 6/group): DCM; chronic pacing (216bpm; 4 weeks).
DCM/ACEI; chronic pace and concomitant ACEI (fosinopril; 30 mg!kg BID).
DCM/AT-BLOCK; chronic pace and treatment with a specific non-peptide AT1
AT-II antagonist (BMS-186295; 30 mg!kg BID), and CONTROL.
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GP531 improved functional recovery in stunned myocardium. and this was
prevented by adenosine receptor blockade with 8SPT, GP531 did not affect
baseline hemodynamics or myocardial function. confirming receptor binding
studies indicating that it is not a direct ADO receptor agonist. We conclude
that GP531 protects the myocardium from ischemic injury in anesthetized
pigs primarily via regulation of endogenous adenosine,
B
mI02/beat/l 00 9
mV02-PVA:A
ml02 /mmHg,ml
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ml/l00 9
ESPVR: Ees
mmHg/ml.l00 9
Mean ± SEM. *p < 0.05 vs. Placebo
1727-21 Changes in Left Ventricular Mechanics and
Energetics in Canine Microembolization Model of
Heart Failure
Koji Todaka. Shu-Ming Zhu. Anguo Gu. Richard Stemett. Daniel Burkhoff. Columbia
University. New York. NY
Myocardial mechanics and energetics have been shown previously to be
markedly abnormal in a canine model of pacing induced heart failure. How-
ever. whether those abnormalities pertain to other. more clinically relevant
forms of heart failure is unknown. To investigate this question, heart failure
was created by ischemic damage in 6 dogs (CHF group) that underwent re-
peated coronary microsphere injections over 2 months resulting in afinal area
ejection fraction (aEF) of 34 ± 4%. A control group of 6 normal dogs had
an aEF of 46 ± 8%, Hearts of these animals were isolated, cross-perfused
and balloons placed in the LV to control volume. We measured the LV end-
systolic (ESPVR) and end-diastolic (EDPVR) pressure-volume relations and
the relationship between oxygen consumption (mV02) and pressure-volume
area (PVA). p-responsiveness of the CHF group was significantly depressed
compared to control as assessed by the increased amount of isoproterenol
required to increase peak isovolumic LV pressure by40% (72 ± 36 vs. 29 ± 14
pg/min. p < 0.05) providing pharmacologic evidence of the heart failure state,
CHF hearts had a depressed and dilated LV as assessed by the ESPVR slope,
Ees, and volume axis intercept, Yo, (both normalized to LV mass) compared
to control (TABLE). EDPVR of CHF hearts was shifted to the right compared to
control. Systolic and diastolic stress-strain relationships. estimated from the
pressure-volume relations. were similar in the two groups. These data sug-
gest that with the degree of chronic ischemic damage achieved, there was
systolic LV chamber dysfunction and chamber remodeling but not myocar-
dial property changes in surviving muscle. The mVOz-PVA relation in CHF
hearts had smaller mV02-intercept (B) than control with no change in the
slope (A) (TABLE), This contrasts with a previous report using a rapid pacing
CHF model in which myocardial strength was decreased, A was decreased
and B was unchanged. These data suggest that 1) in spite of the notable
structural and functional changes in chamber mechanics. energetic aspects
of the failing heart remained unaltered in this model and 2) conclusions about
myocardial energetics in CHF are model dependent.
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1727-31 Regulation of Endogenous Adenosine Improves
Myocardial Functional Recovery Following
Ischemia/Reperfusion Injury
Michael A, Kurz. Kevin Mullane. Mark A. Young. Gensia Inc., San Diego, CA
Adenosine (ADO) has been shown to be cardioprotective following is-
chemia/reperfusion injury. but its utility is limited by profound hemody-
namic side-effects. Therefore, we studied the effects of a novel ADO reg-
ulating agent, GP531 (5-amino-l-p-D-(5-benzylamino-5-deoxy-ribofuranosyl)
imidazole-4-carboxamide), on functional recovery following myocardial stun-
ning in pigs. GP531 does not bind to ADO A1. A2. or A3 receptors, but
increases local endogenous ADO concentrations, Anesthetized pigs were
treated with GP531 (lor 1Ollg!kg/min, iv) orvehicle (saline) in the presence or
absence of the ADO-receptor antagonist 8-sulfophenyltheophylline (8SPT. 83
* p < 0.05. ** P < 0.01 vs. Control by ANCOVA
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Differential Role of Circulating and Ventricular ANP
as a Marker for Cardiac Filling Pressures and
Ventricular Remodeling In a Model of Pacing Induced
Heart Failure and Cardiac Hypertrophy
Margaret M. Redfield. Tracy L, Stevens, Lawrence L. Aarhus, Lane M. Meyer, John
C. Burnett. Jr.. Mayo Clinic. Rochester, MN
Previous studies have suggested that circulating atrial natriuretic peptide
(ANP) is a marker for cardiac filling pressures and ventricular myocardial pro-
duction of ANP a marker for ventricular hypertrophy and/or dilatation. To ad-
dress the role of circulating ANP as a marker for ventricular hypertrophy and
dilatation as compared to cardiac filling pressures, we developed a new ca-
nine model of pacing induced heart failure that in contrast to previous pacing
models produces sustained ventricular hypertrophy. This involves gradually
increasing the pacing rate from 180 to 240 bpm over 30 days (PROG PACE,
n = 5) followed by 4 weeks of recovery (REC. n = 6). Four NORMAL dogs
served as controls, Diastolic dimension (LVEDd) and EF were assessed by
echo, LV mass was assessed by echo prior to rapid ventricular pacing (pre-
RVP) in the PROG PACE (4.2 ± 0.2 g/kg) and REC (4,7 ± 0.2 g/kg) dogs. LV
0,030 ± 0.005**
0036 ± 0004
(13 ± 04) x 10-5
(1,3 ± 0.6) x 10-5
6.9 ± 5.3**
0.5 ± 2,9
3.9 ± 1.2*
47 ± 1.9
CHF
Control
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mass was assessed at autopsy after PROG PACE and REC and in NORMAL
dogs, Ventricular ANP was assessed by sensitive and specific immunohisto-
chemical staining for ANP 1-28,
NORMAL PROG PACE REC
LVEDd (mm) 39 ± 2 50 ± l,t 49 ± l,t
EF(%) 49 ± 5 21 ± 3,t 37 ± 2,t
PCWP(mmHg) 2.3 ± 0.6 21,5 ± 38' 7,5 ± 09'#
CO (Llmin) 313 ± 0,18 1.47 ± 0,23' 3.58 ± 034 #
LV mass (g/kg) 4,6 ± 03 5.4 ± 03 t 55 ± 0.2,t
ANP(pg/mL) 46 ± 8 181 ± 59' 68 ± 15
, = p < 0.05 vs NORMAL; t = p < 0.05 vs pre-RVP; # ~ P < 0.05 vs PROG PACE
Immunohistochemistry was markedly positive for ANP in ventricular my-
ocardium in both PROG PACE and REC dogs, Immunostaining of NORMAL
ventricular myocardium was negative, These studies confirm that circulating
ANP more closely parallels changes in cardiac filling pressures as compared
to cardiac dilatation and/or ventricular hypertrophy, In contrast local ventricu-
lar ANP emerges as a sensitive local tissue marker for ventricular hypertrophy
and dilatation in this novel model of heart failure and ventricular remodeling,
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1727-61 In Vivo Noninvasive Assessment of Left Ventricular
Function in Transgenic Mice with Phospholamban
Deficiency and Over-expression
Saeb F, Khoury, Evangelia G, Kranias, Nancy Ball, Richard A Walsh, Brian D, Hoit
University of Cincinnati: Cincinnat/~ OH
Recent data suggest that phospholamban (PLB) modulates basal and beta
agonist-stimulated myocardial contractility in the isolated heart, To determine
the physiological role of PLB in vivo, anesthetized wild type mice IWT, n = 5)
and transgenic mice with PLB gene targeted ablation (PLB-KO, n = 4) and
overexpression (PLB-DEF, n = 5) were studied with 2D-guided M-mode and
Doppler echo using a 9 MHz imaging and 5-7,5 MHz Doppler transducer
(Interspec CX 200), Data were acquired in the baseline state (BASE) and af-
ter isoproterenol (ISO) injection (1 JLg/mg Lp,), Shortening fraction (SF) was
calculated from M-mode, The peak early transmitral (Ev) and aortic (Aov) ve-
locities and ejection times were measured using Doppler and the heart rate-
corrected velocity of circumferential shortening (Vcfel was calculated,
CON PLB-DEF PLB-OE
BASE ISO BASE ISO BASE ISO
HR (bpm) 282 ± 49 349 ± 55' 322 ± 143 424 ± 43 217 ± 34 355 ± 51'
SF(%) 41 ± 3 64 ± 3' 46± 4 62 ± 3' 41 ± 4 65 ± 4'
Vefe (eire/5) 10 ± 3 22 ± 3' 18 ± 7 27 ± 7 7 ± 1# 20± 4'
Ev (em/sl 40 ± 12 50 ± 3 82 ± lOt 89 ± 16t 44 ± 9# 62 ± 10'#
Aov(em/s) 65 ± 4 75 ± 17 109 ± 15t 108 ± 7t 68±6# 89 ± 7*
mean ± SD; 'p < 0.05 vs BASE; t P < 0,05 vs CON, # vs DEF, ANOVA
We conclude; 1) Phospholamban regulates basal left ventricular function
in vivo and modulates the sensitivity to f3 adrenergic stimulation; 2) Assess-
ment of left ventricular function under varying physiological conditions in
mice can be performed noninvasively,
Non-Invasive Angiography by MR and CT
Monday, March 20,1995,4:00 p,m,-5:30 p,m,
Ernest N. Morial Convention Center, Room 21
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1728-1 I Determination of Stenosis Length by Magnetic
Resonance Coronary Angiography
Walter J, Rogers, Christopher M, Kramer, Therese M, Theobald, Nathaniel Reichek,
Medical College of Pennsylvania, Allegheny General Hospital, Pittsburgh, PA
Magnetic resonance coronary angiography (MRA) can identify significant
stenoses (>50%) as regions with reduced signal intensity due to disturbed
intraluminal flow. To determine whether MRA stenosis length reflects true
lesion length by x-ray angiography (XA). 12 patients (10 male and 2 female;
age 65 ± 8 years) underwent both MRA and XA with an average of 2,1 ± 1,7
days between procedures, MRA was performed with the patient prone on
an elliptical spine coil using a fat suppressed, TurboFlash, breath hold, seg-
mented k-space sequence during late diastole, MRA defects were quantified
off-line by manual tracing of digital images, XA stenoses were analyzed from
35 mm cine films using an electronic caliper which reported defect length,
stenosis diameter and area, Matched MRA-XA stenoses included 5 in the left
anterior descending (LAD). 8 right coronary artery (RCA) and 2 left circumflex
(LCX), MRA and XA results were highly correlated (r = 0,96), MRA reported a
slightly longer stenoses length 9,65 ± 2,0 mm versus 8,32 ± 2,1 mm for XA
(p < 0,05 paired t-test), The ratio (MRA stenosis length/XA stenosis length)
was not dependent on stenosis severity, absolute stenosis lumen diameter
or area (MAN OVA), Thus, in addition to detecting the presence of coronary
lesions, MRA allows quantification of stenosis length,
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1728-21 Current Limitations of Two-Dimensional Breath-Hold
Magnetic Resonance Coronary Angiography
Albert C. van Rossum, Johannes C. Post, Mark B,M, Hofman, Jaap Valk, Cees
A. Visser. Free University Hospital, Amsterdam, The Netherlands; Interuniversity
Cardiology Institute of the Netherlands, Utrecht, The Netherlands
Purpose: Two-dimensional k-space segmented breath-hold magnetic res-
onance angiography (2D-MRA) was recently reported to be a sensitive
and specific technique for the detection of proximal coronary artery (CA)
stenoses, We investigated its accuracy in pts referred for X-ray contrast
coronary angiography(X-CCA) and report on encountered current limitations,
Methods: 20 Pts (17 male; mean age 57 years) referred for X-CCA because
of angina pectoris underwent a 2D-MRA study of the proximal major epicar-
dial Cf>:s (RCA, LMCA, LAD, LCx), X-CCA demonstrated normal Cf>:s in 5 pts,
In 15 pts 7 proximal stenoses of 50-70% (4 RCA, 1 LMCA, 1 LAD, 1 LCx),
11 of 70-90% (4 RCA, 4 LAD, 3 LCx), and 4 >90% (1 LMCA, 3 LAD) were
demonstrated, 1 Mm overlapping images of transverse and oblique orienta-
tions were obtained at 1.5 Tesla, using a surface coil, with pts in prone posi-
tion, A k-space segmented gradient echo acquisition (TE 8 ms, TR 16.4 ms)
with fat-suppression was used, Slice thickness was 4 mm and in-plane res-
olution 1,2 x 2.4 mm2 Images were evaluated by 2 experienced physicians
in consensus for: 1, Identification of major epicardial Cf>:s, 2, Recognition of
side branches and 3, Presence of stenoses, Results: 1, All proximal segments
could be positively identified by 2D-MRA. 2, Identified were segments from
20 out of 31 proximal RCA side branches (65%). 16 out of 30 LAD diagonal
branches (53%) and 1 of 18 LCx obtuse marginal branches (6%), 3, Of 22 sig-
nificant stenoses (>50%! on X-CCA, only2(1 RCA 70-90% and 1 LAD >90%)
were 'surely' demonstrated; 7 stenoses were 'possibly' present (1 RCA 50-
70%,2 RCA 70-90%,1 LM 50-70%, 1 LM >90%,2 LAD 70-90%) and 13
stenoses were judged 'not' to be identified, Conclusions: 2D-MRA is capa-
ble of correctly identifying proximal Cf>:s and segments of 47% of its side
branches, but in its current state has a low sensitivity (41 %, including 'possi-
ble' identifications) for the detection of significant CA stenoses,
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Contrast-enhanced Electron Beam Tomography for
3-D Reconstruction of Coronary Arteries: Detection
of Stenoses and Documentation of Angioplasty
Success
Werner E, Moshage, Stephan Achenbach, Bernd Seese, Kurt Bachmann,
Gudrun Hach, Markus Kirchgeorg, Medical Clinic /I (Cardiology), University of
Erlangen-Nurnberg, Germany
Non-invasive imaging of coronary arteries is complicated by their very
fast movements, We evaluated the potential of contrast-enhanced Electron
Beam Tomography (EBT, Ultrafast-CT) for the visualization of coronary artery
stenoses,
24 patients with angiographically documented coronary artery disease
were investigated, In 5 patients, EBT was repeated after angioplasty, Con-
trast agent was administered via a peripheral vein and ECG-triggered axial
EBT scans were obtained during breathhold (acquisition time 100 ms/slice,
table movement 2 mm/slice, slice thickness 3 mm), 3-D reconstruction of the
coronary arteries was performed as shaded surface display with a density
